SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

Nabriva Therapeutics Reports Resubmission Of New Drug Application For Intravenous CONTEPO For Injection

Benzinga · 12/20/2019 11:00